Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure

Monica Neri, Rosangela Filiberti, Emanuela Taioli, Seymour Garte, Valentina Paracchini, Claudia Bolognesi, Pier Aldo Canessa, Vincenzo Fontana, Giovanni Paolo Ivaldi, Anna Verna, Stefano Bonassi, Riccardo Puntoni

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Pleural malignant mesothelioma (MM) is a rare but extremely aggressive cancer. The limited impact of standard therapeutic treatments on survival rates makes the identification of factors that increase the individual risk a leading priority. The high proportion of cases explained by exposure to asbestos has guided intervention policies to an effective ban of this compound from our environment. However, MM cannot be solely attributed to this agent, and the role of predisposing factors and their interaction with asbestos exposure is increasingly studied. The role of mEH, GSTM1, GSTT1, NAT2, and CYP1A1 genotypes in modulating susceptibility to MM was examined in a case-control study of 80 subjects with a confirmed diagnosis of MM and 255 controls. Subjects with low mEH activity showed a significantly increased risk of MM (OR, 2.51; 95% CI, 1.11-5.68). The association was stronger in the group with low asbestos exposure (OR, 7.83; 95% CI, 0.98-62.60). A significant increased risk of MM was also found in NAT2 fast acetylators (OR, 1.74; 95% CI, 1.02-2.96). The presence of synergisms between genotypes, i.e., mEH and NAT2 (LRT for heterogeneity p <0.023), mEH and GSTM1 (LRT p <0.061), and NAT2 and GSTM1 (LRT p <0.049), combined with the interaction observed with exposure to asbestos, suggests the presence of gene-environment and gene-gene interactions in the development of MM, although the size of the study group does not allow to draw clearcut conclusions. Since genetic polymorphisms can also modify the extent of genetic damage occurring in subjects exposed to carcinogens, we measured the frequency of micronuclei in peripheral blood lymphocytes of a subgroup of MM cases. The limited number of cases (28) did not allow to observe significant effects. In conclusion, these results strengthen the hypothesis that individual susceptibility to MM can be modulated by the interaction between polymorphic genes involved in the metabolism and the intensity of asbestos exposure.

Original languageEnglish
Pages (from-to)36-44
Number of pages9
JournalMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Volume592
Issue number1-2
DOIs
Publication statusPublished - Dec 30 2005

Fingerprint

Asbestos
Genetic Predisposition to Disease
Genes
Genotype
Malignant Mesothelioma
Cytochrome P-450 CYP1A1
Genetic Polymorphisms
Causality
Carcinogens
Case-Control Studies
Survival Rate
Lymphocytes

Keywords

  • Asbestos
  • CYP1A1
  • Gene-environment interaction
  • GSTM1
  • GSTT1
  • Malignant mesothelioma
  • mEH
  • NAT2

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Molecular Biology

Cite this

Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure. / Neri, Monica; Filiberti, Rosangela; Taioli, Emanuela; Garte, Seymour; Paracchini, Valentina; Bolognesi, Claudia; Canessa, Pier Aldo; Fontana, Vincenzo; Ivaldi, Giovanni Paolo; Verna, Anna; Bonassi, Stefano; Puntoni, Riccardo.

In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 592, No. 1-2, 30.12.2005, p. 36-44.

Research output: Contribution to journalArticle

Neri, Monica ; Filiberti, Rosangela ; Taioli, Emanuela ; Garte, Seymour ; Paracchini, Valentina ; Bolognesi, Claudia ; Canessa, Pier Aldo ; Fontana, Vincenzo ; Ivaldi, Giovanni Paolo ; Verna, Anna ; Bonassi, Stefano ; Puntoni, Riccardo. / Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure. In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 2005 ; Vol. 592, No. 1-2. pp. 36-44.
@article{2bcb5c7ef4df49ff8145849db7b79cc1,
title = "Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure",
abstract = "Pleural malignant mesothelioma (MM) is a rare but extremely aggressive cancer. The limited impact of standard therapeutic treatments on survival rates makes the identification of factors that increase the individual risk a leading priority. The high proportion of cases explained by exposure to asbestos has guided intervention policies to an effective ban of this compound from our environment. However, MM cannot be solely attributed to this agent, and the role of predisposing factors and their interaction with asbestos exposure is increasingly studied. The role of mEH, GSTM1, GSTT1, NAT2, and CYP1A1 genotypes in modulating susceptibility to MM was examined in a case-control study of 80 subjects with a confirmed diagnosis of MM and 255 controls. Subjects with low mEH activity showed a significantly increased risk of MM (OR, 2.51; 95{\%} CI, 1.11-5.68). The association was stronger in the group with low asbestos exposure (OR, 7.83; 95{\%} CI, 0.98-62.60). A significant increased risk of MM was also found in NAT2 fast acetylators (OR, 1.74; 95{\%} CI, 1.02-2.96). The presence of synergisms between genotypes, i.e., mEH and NAT2 (LRT for heterogeneity p <0.023), mEH and GSTM1 (LRT p <0.061), and NAT2 and GSTM1 (LRT p <0.049), combined with the interaction observed with exposure to asbestos, suggests the presence of gene-environment and gene-gene interactions in the development of MM, although the size of the study group does not allow to draw clearcut conclusions. Since genetic polymorphisms can also modify the extent of genetic damage occurring in subjects exposed to carcinogens, we measured the frequency of micronuclei in peripheral blood lymphocytes of a subgroup of MM cases. The limited number of cases (28) did not allow to observe significant effects. In conclusion, these results strengthen the hypothesis that individual susceptibility to MM can be modulated by the interaction between polymorphic genes involved in the metabolism and the intensity of asbestos exposure.",
keywords = "Asbestos, CYP1A1, Gene-environment interaction, GSTM1, GSTT1, Malignant mesothelioma, mEH, NAT2",
author = "Monica Neri and Rosangela Filiberti and Emanuela Taioli and Seymour Garte and Valentina Paracchini and Claudia Bolognesi and Canessa, {Pier Aldo} and Vincenzo Fontana and Ivaldi, {Giovanni Paolo} and Anna Verna and Stefano Bonassi and Riccardo Puntoni",
year = "2005",
month = "12",
day = "30",
doi = "10.1016/j.mrfmmm.2005.06.003",
language = "English",
volume = "592",
pages = "36--44",
journal = "Mutation Research",
issn = "0027-5107",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure

AU - Neri, Monica

AU - Filiberti, Rosangela

AU - Taioli, Emanuela

AU - Garte, Seymour

AU - Paracchini, Valentina

AU - Bolognesi, Claudia

AU - Canessa, Pier Aldo

AU - Fontana, Vincenzo

AU - Ivaldi, Giovanni Paolo

AU - Verna, Anna

AU - Bonassi, Stefano

AU - Puntoni, Riccardo

PY - 2005/12/30

Y1 - 2005/12/30

N2 - Pleural malignant mesothelioma (MM) is a rare but extremely aggressive cancer. The limited impact of standard therapeutic treatments on survival rates makes the identification of factors that increase the individual risk a leading priority. The high proportion of cases explained by exposure to asbestos has guided intervention policies to an effective ban of this compound from our environment. However, MM cannot be solely attributed to this agent, and the role of predisposing factors and their interaction with asbestos exposure is increasingly studied. The role of mEH, GSTM1, GSTT1, NAT2, and CYP1A1 genotypes in modulating susceptibility to MM was examined in a case-control study of 80 subjects with a confirmed diagnosis of MM and 255 controls. Subjects with low mEH activity showed a significantly increased risk of MM (OR, 2.51; 95% CI, 1.11-5.68). The association was stronger in the group with low asbestos exposure (OR, 7.83; 95% CI, 0.98-62.60). A significant increased risk of MM was also found in NAT2 fast acetylators (OR, 1.74; 95% CI, 1.02-2.96). The presence of synergisms between genotypes, i.e., mEH and NAT2 (LRT for heterogeneity p <0.023), mEH and GSTM1 (LRT p <0.061), and NAT2 and GSTM1 (LRT p <0.049), combined with the interaction observed with exposure to asbestos, suggests the presence of gene-environment and gene-gene interactions in the development of MM, although the size of the study group does not allow to draw clearcut conclusions. Since genetic polymorphisms can also modify the extent of genetic damage occurring in subjects exposed to carcinogens, we measured the frequency of micronuclei in peripheral blood lymphocytes of a subgroup of MM cases. The limited number of cases (28) did not allow to observe significant effects. In conclusion, these results strengthen the hypothesis that individual susceptibility to MM can be modulated by the interaction between polymorphic genes involved in the metabolism and the intensity of asbestos exposure.

AB - Pleural malignant mesothelioma (MM) is a rare but extremely aggressive cancer. The limited impact of standard therapeutic treatments on survival rates makes the identification of factors that increase the individual risk a leading priority. The high proportion of cases explained by exposure to asbestos has guided intervention policies to an effective ban of this compound from our environment. However, MM cannot be solely attributed to this agent, and the role of predisposing factors and their interaction with asbestos exposure is increasingly studied. The role of mEH, GSTM1, GSTT1, NAT2, and CYP1A1 genotypes in modulating susceptibility to MM was examined in a case-control study of 80 subjects with a confirmed diagnosis of MM and 255 controls. Subjects with low mEH activity showed a significantly increased risk of MM (OR, 2.51; 95% CI, 1.11-5.68). The association was stronger in the group with low asbestos exposure (OR, 7.83; 95% CI, 0.98-62.60). A significant increased risk of MM was also found in NAT2 fast acetylators (OR, 1.74; 95% CI, 1.02-2.96). The presence of synergisms between genotypes, i.e., mEH and NAT2 (LRT for heterogeneity p <0.023), mEH and GSTM1 (LRT p <0.061), and NAT2 and GSTM1 (LRT p <0.049), combined with the interaction observed with exposure to asbestos, suggests the presence of gene-environment and gene-gene interactions in the development of MM, although the size of the study group does not allow to draw clearcut conclusions. Since genetic polymorphisms can also modify the extent of genetic damage occurring in subjects exposed to carcinogens, we measured the frequency of micronuclei in peripheral blood lymphocytes of a subgroup of MM cases. The limited number of cases (28) did not allow to observe significant effects. In conclusion, these results strengthen the hypothesis that individual susceptibility to MM can be modulated by the interaction between polymorphic genes involved in the metabolism and the intensity of asbestos exposure.

KW - Asbestos

KW - CYP1A1

KW - Gene-environment interaction

KW - GSTM1

KW - GSTT1

KW - Malignant mesothelioma

KW - mEH

KW - NAT2

UR - http://www.scopus.com/inward/record.url?scp=28244459960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28244459960&partnerID=8YFLogxK

U2 - 10.1016/j.mrfmmm.2005.06.003

DO - 10.1016/j.mrfmmm.2005.06.003

M3 - Article

C2 - 15993904

AN - SCOPUS:28244459960

VL - 592

SP - 36

EP - 44

JO - Mutation Research

JF - Mutation Research

SN - 0027-5107

IS - 1-2

ER -